Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Early treatment helps stop hair loss in women of color.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Wigs greatly improve life quality for hair loss patients.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

The article concludes that different types of hair loss require specific treatments and psychological support is important.